Professor in Molecular LymphopoiesisUniversity of GlasgowGlasgow, Scotland, United Kingdom
N/A
(1551862) Exploiting the modulation of FOXO1 signalling as a therapeutic target in CLL through combination of ERK and BTK inhibition
Saturday, October 7, 20233:15 PM – 3:25 PM EDT